Response to Dahl et al.: Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetes

Diabetes Obes Metab. 2021 Oct;23(10):2411-2413. doi: 10.1111/dom.14473. Epub 2021 Jul 16.

Authors

Michael Horowitz^{1

2}, Christopher K Rayner^{1

3}, Chinmay S Marathe^{1

2}, Tongzhi Wu^{1

2}, Mahesh Umapathysivam^{1

2}, Karen L Jones^{1

2}

Affiliations

¹ Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.
² Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
³ Department of Gastroenterology and Hepatology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.

PMID: 34169640
DOI: 10.1111/dom.14473

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Diabetes Mellitus, Type 2* / drug therapy
Gastric Emptying*
Glucagon-Like Peptides
Glucose
Humans
Lipid Metabolism
Postprandial Period

Substances

semaglutide
Glucagon-Like Peptides
Glucose